Source: Eur Respir J 2015; 46: 1551-1553



Rating:

Share or cite this content

Citations should be made in the following way:
Meyer Guy, Planquette Benjamin, Sanchez Olivier. Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?. Eur Respir J 2015; 46: 1551-1553

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary embolism risk stratification: where are we heading? Source: Eur Respir J 2014; 43: 298-300 Year: 2004 A radiological grading system for risk stratification of acute pulmonary embolism: A pilot study Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Do we ever learn? Risk stratification and investigation of suspected pulmonary embolism Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013 Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Comparison of risk assessment strategies for not-high-risk pulmonary embolism Source: Eur Respir J 2016; 47: 1170-1178 Year: 2016 Severe pulmonary sarcoidosis: definition and risk stratification Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Is it time for home treatment of pulmonary embolism Source: Eur Respir J 2012; 40: 742-749 Year: 2012 Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin Source: Eur Respir J 2015; 46: 1701-1710 Year: 2015 Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017 Year: 2017 Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018 Original, simplified, and modified pulmonary embolism severity indices in risk stratification of pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Validation of a prognostic score for pulmonary embolism short-term mortality Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 Comparison of three clinical prediction rules among patients with suspected pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 685s Year: 2004 Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE) Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Pulmonary embolism in young people: risk factors and clinical presentation Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017 Validation of a non-invasive diagnostic algorithm in assessment of patients with clinical suspicion of pulmonary embolism Source: Eur Respir J 2002; 20: Suppl. 38, 238s Year: 2002